3 Patents
- US124923892025Modified Cas9 System Having a Dominant Negative Effector on Non-homologous End-joining Fused Thereto and Its Use for Improved Gene Editing
Albert-ludwigs-universitaet Freiburg
0 cites - US119577942024Biodegradable Multilayer Nanocapsules for the Delivery of Biologically Active Agents in Target Cells
Queen Mary University Of London
0 cites - US117675122023Sequence Specific Reagents Targeting CCR5 in Primary Hematopoietic Cells
ALBERT-LUDWIGS-UNIVERSITAT FREIBURG
0 cites